Input interpretation
![adenosine](../image_source/398a090216d291aa9ad553a262306742.png)
adenosine
Chemical names and formulas
![formula | C_10H_13N_5O_4 name | adenosine IUPAC name | (3R, 4S, 5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3, 4-diol alternate names | adenocard | adenoscan | beta-adenosine | boniton | myocol | sandesin mass fractions | C (carbon) 44.9% | H (hydrogen) 4.9% | N (nitrogen) 26.2% | O (oxygen) 23.9%](../image_source/41bf9634b6734fc988060e65dcfe3a20.png)
formula | C_10H_13N_5O_4 name | adenosine IUPAC name | (3R, 4S, 5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3, 4-diol alternate names | adenocard | adenoscan | beta-adenosine | boniton | myocol | sandesin mass fractions | C (carbon) 44.9% | H (hydrogen) 4.9% | N (nitrogen) 26.2% | O (oxygen) 23.9%
Lewis structure
![Draw the Lewis structure of adenosine. Start by drawing the overall structure of the molecule, ignoring potential double and triple bonds: Count the total valence electrons of the carbon (n_C, val = 4), hydrogen (n_H, val = 1), nitrogen (n_N, val = 5), and oxygen (n_O, val = 6) atoms: 10 n_C, val + 13 n_H, val + 5 n_N, val + 4 n_O, val = 102 Calculate the number of electrons needed to completely fill the valence shells for carbon (n_C, full = 8), hydrogen (n_H, full = 2), nitrogen (n_N, full = 8), and oxygen (n_O, full = 8): 10 n_C, full + 13 n_H, full + 5 n_N, full + 4 n_O, full = 178 Subtracting these two numbers shows that 178 - 102 = 76 bonding electrons are needed. Each bond has two electrons, so in addition to the 34 bonds already present in the diagram add 4 bonds. To minimize formal charge nitrogen wants 3 bonds and carbon wants 4 bonds. Identify the atoms that want additional bonds and the number of electrons remaining on each atom: Fill in the 4 bonds by pairing electrons between adjacent highlighted atoms. Note that the six atom ring is aromatic, so that the single and double bonds may be rearranged: Answer: | |](../image_source/cfa94270ccf8e3d7fa52dc07e0d320d8.png)
Draw the Lewis structure of adenosine. Start by drawing the overall structure of the molecule, ignoring potential double and triple bonds: Count the total valence electrons of the carbon (n_C, val = 4), hydrogen (n_H, val = 1), nitrogen (n_N, val = 5), and oxygen (n_O, val = 6) atoms: 10 n_C, val + 13 n_H, val + 5 n_N, val + 4 n_O, val = 102 Calculate the number of electrons needed to completely fill the valence shells for carbon (n_C, full = 8), hydrogen (n_H, full = 2), nitrogen (n_N, full = 8), and oxygen (n_O, full = 8): 10 n_C, full + 13 n_H, full + 5 n_N, full + 4 n_O, full = 178 Subtracting these two numbers shows that 178 - 102 = 76 bonding electrons are needed. Each bond has two electrons, so in addition to the 34 bonds already present in the diagram add 4 bonds. To minimize formal charge nitrogen wants 3 bonds and carbon wants 4 bonds. Identify the atoms that want additional bonds and the number of electrons remaining on each atom: Fill in the 4 bonds by pairing electrons between adjacent highlighted atoms. Note that the six atom ring is aromatic, so that the single and double bonds may be rearranged: Answer: | |
3D structure
![3D structure](../image_source/cf667456ed2512057d3665cc5e527c8d.png)
3D structure
Basic properties
![molar mass | 267.25 g/mol phase | solid (at STP) melting point | 235 °C boiling point | 676 °C density | 0.99224 g/cm^3 solubility in water | soluble](../image_source/8309c21c1a2df43648cb691e5c87e5b0.png)
molar mass | 267.25 g/mol phase | solid (at STP) melting point | 235 °C boiling point | 676 °C density | 0.99224 g/cm^3 solubility in water | soluble
Units
Hydrophobicity and permeability properties
![experimental LogP hydrophobicity | -1.6 predicted LogP hydrophobicity | -1.2 predicted LogS | -1.28](../image_source/97ae36bc36814ed1f570586205f366ae.png)
experimental LogP hydrophobicity | -1.6 predicted LogP hydrophobicity | -1.2 predicted LogS | -1.28
Drug interactions
![aminophylline | dipyridamole | 7-(2, 3-dihydroxypropyl)theophylline | 7-(2, 3-dihydroxypropyl)theophylline | oxtriphylline | theophylline | theophylline (total: 7)](../image_source/9c2af64cb8bdc0dfd411ae4393e78551.png)
aminophylline | dipyridamole | 7-(2, 3-dihydroxypropyl)theophylline | 7-(2, 3-dihydroxypropyl)theophylline | oxtriphylline | theophylline | theophylline (total: 7)
Basic drug properties
![approval status | approved | investigational | small molecule drug categories | analgesic | anti-arrhythmia agent | antiarrhythmic agent | cardiac drug | vasodilator agent dosage forms | intravenous: liquid | intravenous: solution](../image_source/f53a425af78518f986bbd6eec815eb2f.png)
approval status | approved | investigational | small molecule drug categories | analgesic | anti-arrhythmia agent | antiarrhythmic agent | cardiac drug | vasodilator agent dosage forms | intravenous: liquid | intravenous: solution
![brand names | adenocard | adenocor | adenoscan | adenosin | adensoine | boniton | myocol | nucleocardyl | pallacor | sandesin](../image_source/17e7903c0511833a595ba7b4af346ecf.png)
brand names | adenocard | adenocor | adenoscan | adenosin | adensoine | boniton | myocol | nucleocardyl | pallacor | sandesin
Solid properties (at STP)
![density | 0.99224 g/cm^3 vapor pressure | 3×10^-19 mmHg (at 25 °C)](../image_source/bb47eeb5f09d5ea2ef2214d4b3c186c8.png)
density | 0.99224 g/cm^3 vapor pressure | 3×10^-19 mmHg (at 25 °C)
Units
Thermodynamic properties
![molar heat of vaporization | 104.3 kJ/mol specific heat of vaporization | 0.3903 kJ/g molar heat of combustion | 5139 kJ/mol specific heat of combustion | 19.23 kJ/g (at STP)](../image_source/4f49a4dcdabc28783fcc51a81e1d61c5.png)
molar heat of vaporization | 104.3 kJ/mol specific heat of vaporization | 0.3903 kJ/g molar heat of combustion | 5139 kJ/mol specific heat of combustion | 19.23 kJ/g (at STP)
Chemical identifiers
![CAS number | 58-61-7 Beilstein number | 93029 PubChem CID number | 60961 PubChem SID number | 3512 SMILES identifier | C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)CO)O)O InChI identifier | InChI=1/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4, 6-7, 10, 16-18H, 1H2, (H2, 11, 12, 13)/t4-, 6-, 7-, 10-/m1/s1/f/h11H2 InChI key | OIRDTQYFTABQOQ-ONGDMJDYDQ EU number | 200-389-9 RTECS number | AU7175000 NSC number | 7652](../image_source/2e96c47dd1aedc58cac4adaf87eb82ab.png)
CAS number | 58-61-7 Beilstein number | 93029 PubChem CID number | 60961 PubChem SID number | 3512 SMILES identifier | C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)CO)O)O InChI identifier | InChI=1/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4, 6-7, 10, 16-18H, 1H2, (H2, 11, 12, 13)/t4-, 6-, 7-, 10-/m1/s1/f/h11H2 InChI key | OIRDTQYFTABQOQ-ONGDMJDYDQ EU number | 200-389-9 RTECS number | AU7175000 NSC number | 7652
NFPA label
![NFPA label](../image_source/7d0ae58fe531e710b9dea83d73731ffb.png)
NFPA label
![NFPA health rating | 1 NFPA fire rating | 0 NFPA reactivity rating | 0](../image_source/6996e31073c8357e9462aead27730636.png)
NFPA health rating | 1 NFPA fire rating | 0 NFPA reactivity rating | 0
Safety properties
![flash point | 362 °C](../image_source/95293a61474613d067e7b3e14e9b8cb8.png)
flash point | 362 °C
Toxicity properties
![RTECS classes | drug | mutagen | human data](../image_source/967fe011f02523309bbc94f8eeda9e9e.png)
RTECS classes | drug | mutagen | human data